[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2011 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- -1.71%
YoY- -6.85%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 133,242 140,824 144,228 138,132 140,128 136,658 131,936 0.65%
PBT 35,064 35,812 35,476 34,728 35,856 34,332 31,500 7.38%
Tax -8,374 -8,662 -8,644 -8,023 -8,686 -8,620 -7,804 4.79%
NP 26,689 27,150 26,832 26,705 27,169 25,712 23,696 8.22%
-
NP to SH 26,689 27,150 26,832 26,705 27,169 25,712 23,696 8.22%
-
Tax Rate 23.88% 24.19% 24.37% 23.10% 24.22% 25.11% 24.77% -
Total Cost 106,553 113,674 117,396 111,427 112,958 110,946 108,240 -1.03%
-
Net Worth 167,965 162,400 170,824 163,783 162,405 154,105 162,320 2.29%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div - 9,716 - 24,983 - 9,718 - -
Div Payout % - 35.79% - 93.56% - 37.80% - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 167,965 162,400 170,824 163,783 162,405 154,105 162,320 2.29%
NOSH 138,814 138,803 138,881 138,799 138,807 138,833 138,735 0.03%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 20.03% 19.28% 18.60% 19.33% 19.39% 18.81% 17.96% -
ROE 15.89% 16.72% 15.71% 16.31% 16.73% 16.68% 14.60% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 95.99 101.46 103.85 99.52 100.95 98.43 95.10 0.62%
EPS 19.23 19.56 19.32 19.24 19.57 18.52 17.08 8.20%
DPS 0.00 7.00 0.00 18.00 0.00 7.00 0.00 -
NAPS 1.21 1.17 1.23 1.18 1.17 1.11 1.17 2.26%
Adjusted Per Share Value based on latest NOSH - 138,793
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 13.85 14.64 14.99 14.36 14.57 14.21 13.72 0.62%
EPS 2.77 2.82 2.79 2.78 2.82 2.67 2.46 8.21%
DPS 0.00 1.01 0.00 2.60 0.00 1.01 0.00 -
NAPS 0.1746 0.1688 0.1776 0.1703 0.1688 0.1602 0.1687 2.31%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 2.36 2.23 2.40 2.02 2.10 2.34 2.35 -
P/RPS 2.46 2.20 2.31 2.03 2.08 2.38 2.47 -0.26%
P/EPS 12.27 11.40 12.42 10.50 10.73 12.63 13.76 -7.33%
EY 8.15 8.77 8.05 9.52 9.32 7.91 7.27 7.89%
DY 0.00 3.14 0.00 8.91 0.00 2.99 0.00 -
P/NAPS 1.95 1.91 1.95 1.71 1.79 2.11 2.01 -1.99%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 23/11/12 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 25/05/11 -
Price 2.28 2.38 2.38 2.12 2.10 2.22 2.57 -
P/RPS 2.38 2.35 2.29 2.13 2.08 2.26 2.70 -8.04%
P/EPS 11.86 12.17 12.32 11.02 10.73 11.99 15.05 -14.64%
EY 8.43 8.22 8.12 9.08 9.32 8.34 6.65 17.08%
DY 0.00 2.94 0.00 8.49 0.00 3.15 0.00 -
P/NAPS 1.88 2.03 1.93 1.80 1.79 2.00 2.20 -9.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment